Zacks Research Brokers Reduce Earnings Estimates for Perrigo

Perrigo Company plc (NYSE:PRGOFree Report) – Stock analysts at Zacks Research dropped their Q1 2025 EPS estimates for shares of Perrigo in a note issued to investors on Thursday, March 20th. Zacks Research analyst S. Ganoria now expects that the company will post earnings of $0.44 per share for the quarter, down from their previous estimate of $0.52. The consensus estimate for Perrigo’s current full-year earnings is $2.56 per share. Zacks Research also issued estimates for Perrigo’s Q2 2025 earnings at $0.70 EPS, Q3 2025 earnings at $0.79 EPS, FY2025 earnings at $2.93 EPS, Q1 2026 earnings at $0.55 EPS, Q2 2026 earnings at $0.84 EPS, Q3 2026 earnings at $0.83 EPS, Q4 2026 earnings at $0.99 EPS, FY2026 earnings at $3.20 EPS and FY2027 earnings at $3.51 EPS.

A number of other equities research analysts have also weighed in on the stock. Argus lowered shares of Perrigo from a “buy” rating to a “hold” rating in a report on Tuesday, January 14th. Piper Sandler cut shares of Perrigo from an “overweight” rating to a “neutral” rating and decreased their price objective for the company from $34.00 to $27.00 in a research report on Monday, January 6th. Finally, StockNews.com lowered Perrigo from a “buy” rating to a “hold” rating in a research report on Wednesday, February 19th. Four investment analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat, Perrigo presently has an average rating of “Hold” and a consensus price target of $33.00.

View Our Latest Stock Report on PRGO

Perrigo Stock Down 1.8 %

Shares of NYSE:PRGO opened at $27.25 on Monday. The company has a 50 day moving average of $25.87 and a two-hundred day moving average of $26.14. Perrigo has a 52-week low of $23.14 and a 52-week high of $33.46. The company has a quick ratio of 1.77, a current ratio of 2.56 and a debt-to-equity ratio of 0.94. The company has a market capitalization of $3.72 billion, a price-to-earnings ratio of -23.29 and a beta of 0.48.

Perrigo (NYSE:PRGOGet Free Report) last issued its quarterly earnings data on Thursday, February 27th. The company reported $0.93 EPS for the quarter, topping analysts’ consensus estimates of $0.92 by $0.01. The company had revenue of $1.14 billion for the quarter, compared to analysts’ expectations of $1.20 billion. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Price T Rowe Associates Inc. MD boosted its holdings in shares of Perrigo by 6,828.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 7,845,539 shares of the company’s stock valued at $201,710,000 after acquiring an additional 7,732,309 shares during the period. Dimensional Fund Advisors LP boosted its stake in Perrigo by 0.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 6,989,530 shares of the company’s stock valued at $179,698,000 after purchasing an additional 27,835 shares during the period. Deprince Race & Zollo Inc. boosted its stake in Perrigo by 1.1% during the 4th quarter. Deprince Race & Zollo Inc. now owns 4,557,844 shares of the company’s stock valued at $117,182,000 after purchasing an additional 50,728 shares during the period. Cooke & Bieler LP grew its position in Perrigo by 4.1% in the 4th quarter. Cooke & Bieler LP now owns 3,573,651 shares of the company’s stock worth $91,879,000 after purchasing an additional 139,650 shares during the last quarter. Finally, Ion Asset Management Ltd. increased its stake in shares of Perrigo by 50.1% in the fourth quarter. Ion Asset Management Ltd. now owns 2,820,000 shares of the company’s stock valued at $72,502,000 after purchasing an additional 941,667 shares during the period. Institutional investors and hedge funds own 95.91% of the company’s stock.

Insider Activity at Perrigo

In other news, EVP Ronald Craig Janish sold 7,800 shares of the company’s stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $27.44, for a total transaction of $214,032.00. Following the completion of the transaction, the executive vice president now directly owns 33,666 shares of the company’s stock, valued at approximately $923,795.04. This represents a 18.81 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.70% of the company’s stock.

Perrigo Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 25th. Stockholders of record on Friday, March 7th were issued a $0.29 dividend. This represents a $1.16 dividend on an annualized basis and a dividend yield of 4.26%. This is an increase from Perrigo’s previous quarterly dividend of $0.28. The ex-dividend date was Friday, March 7th. Perrigo’s payout ratio is -92.80%.

About Perrigo

(Get Free Report)

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.

Recommended Stories

Earnings History and Estimates for Perrigo (NYSE:PRGO)

Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.